{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:59:45Z","timestamp":1762001985208,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ymgmr.2022.100846","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T06:00:11Z","timestamp":1643695211000},"page":"100846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria"],"prefix":"10.1016","volume":"30","author":[{"given":"L.R.","family":"Ranganath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Milan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.P.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bou-Gharios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gornall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Imrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rovensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2022.100846_bb0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9343(63)90089-5","article-title":"Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584\u20131962)","volume":"34","author":"O\u2019Brien","year":"1963","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0010","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of alkaptonuria","volume":"347","author":"Phornphutkul","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2011.04.016","article-title":"A 3-year randomized therapeutic trial of nitisinone in alkaptonuria","volume":"103","author":"Introne","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2018.07.011","article-title":"Nitisinone arrests ochronosis and decreases rate of progression of alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre","volume":"125","author":"Ranganath","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0025","unstructured":"First treatment for rare metabolic disorder alkaptonuria. https:\/\/www.ema.europa.eu\/en\/news\/first-treatment-raremetabolic-disorder-alkaptonuria. Accessed December 1, 2021."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2213-8587(20)30228-X","article-title":"Suitability of nitisinone in alkaptonuria 2 (SONIA 2) - a randomised study on the efficacy and safety of nitisinone in alkaptonuria","volume":"8","author":"Ranganath","year":"2020","journal-title":"Lancet Diabet.Endocrinol."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0035","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1038\/s41598-019-46033-x","article-title":"Unmasking nature: quantification of tyrosine flux in the ochronotic pathway during nitisinone treatment of alkaptonuria","volume":"9","author":"Milan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0040","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jimd.12229","article-title":"Nitisinone causes acquired tyrosinosis in alkaptonuria","volume":"43","author":"Khedr","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0045","first-page":"1","article-title":"Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report","volume":"17","author":"Stewart","year":"2014","journal-title":"JIMD Rep."},{"issue":"8823","key":"10.1016\/j.ymgmr.2022.100846_bb0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2022.100846_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-016-0472-5","article-title":"Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls","volume":"11","author":"van Ginkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100846_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/21678707.2013.800807","article-title":"Nitisinone for the treatment of hereditary tyrosinemia type I","volume":"1","author":"McKiernan","year":"2013","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgmr.2022.100846_bb0065","first-page":"21","article-title":"Relationship between serum concentrations of nitisinone and its effect on homogentisic acid and tyrosine in patients with alkaptonuria","volume":"24","author":"Olsson","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"Ranganath","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0004563215571969","article-title":"Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry","volume":"52","author":"Hughes","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12072-007-9019-0","article-title":"Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis","volume":"1","author":"Kida","year":"2007","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A method for estimating nitrogen intake of patients with chronic renal failure","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2891-12-60","article-title":"Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations","volume":"12","author":"Gr\u00fcnert","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-201X.1998.00306.x","article-title":"Exercise-induced changes in protein metabolism","volume":"162","author":"Tipton","year":"1998","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1242\/jeb.160.1.149","article-title":"Effect of exercise on amino acid concentrations in skeletal muscle and plasma","volume":"160","author":"Henriksson","year":"1991","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/taap.1995.1121","article-title":"Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulphonylbenzoyl)-cyclohexane-1,3-dione","volume":"133","author":"Ellis","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/taap.1996.0310","article-title":"Tissue distribution of 2-(2- nitro-4 trifluromethylbenzoyl)-1,3-cyclohexanedione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat","volume":"141","author":"Lock","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jimd.12172","article-title":"Dietary restriction of tyrosine and phenylalanine lowers nitisinone-induced tyrosinaemia in the alkaptonuria mouse model","volume":"43","author":"Hughes","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0120","first-page":"1","article-title":"Vitiligo, alkaptonuria, and nitisinone \u2013 a report of four cases and review of the literature","author":"Ranganath","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1023\/A:1005458703363","article-title":"From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug","volume":"21","author":"Lock","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1","volume":"8","author":"de Laet","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0135","article-title":"Comparing nitisinone 2mg and 10mg in the treatment of alkaptonuria \u2013 an approach using statistical modelling","volume":"1\u201313","author":"Ranganath","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0140","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/jn\/127.9.1842","article-title":"Human amino acid requirements","volume":"127","author":"Millward","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgmr.2022.100846_bb0145","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1002\/ece3.3096","article-title":"Evolutionary implications of Liebig\u2019s law of the minimum: selection under low concentrations of two nonsubstitutable nutrients","volume":"7","author":"Warsi","year":"2017","journal-title":"Ecol.Evol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:48Z","timestamp":1762001568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":29,"alternative-id":["S2214426922000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100846","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100846"}}